Puma Biotechnology

Puma Biotechnology

World Rank (Jan-05-2024)
17,684
Market Cap (Jan-05-2024)
0.208 Billion USD
World Rank (Jul-30-2023)
18,982
Market Cap (Jul-30-2023)
0.168 Billion USD
World Rank (Jan-07-2022)
22,160
Market Cap (Jan-07-2022)
0.114 Billion USD
World Rank (Jan-01-2021)
12,159
Market Cap (Jan-01-2021)
0.408 Billion USD
Headquarters Country
USA
Nasdaq / NYSE Code
PBYI
Market Cap (Mar-08-2026)
0.31
Headquarters City/State
California
World Region
Americas
World Subregion
Northern America
Annual Revenue in USD
225 Million USD
Annual Net Income in USD
-60 Million USD
Annual Results for Period Ending
Dec-2020 ending year
Balance Sheet for Period Ending
Dec-2020 ending year
Business Sector
Healthcare
HealthCare Products
Biotechnology
Company Website
PUMA BIOTECHNOLOGY INC
Yahoo
Yahoo @ Nasdaq
Company Profile
Puma Biotechnology is a Biopharmaceutical company focus on in-licensing innovative drug candidates that are undergoing or have already completed initial clinical testing for the treatment of various forms of cancer and then seek to further develop these drug candidates for commercial use. The company annual revenue is 272.1 million USD and 272 employees as on 2020. The headquarters is in USA.
Stock Exchange
Nasdaq
Frankfurt
Company SubCategory
Top Healthcare Companies in USA
Nasdaq Sector
Health Care
Nasdaq Industry
Biotechnology: Pharmaceutical Preparations

Share